Try our Advanced Search for more refined results
Intellectual Property UK
-
June 10, 2024
Gilead Beats Fresh Challenge To Hepatitis C Drug Patent
Gilead Pharmasset LLC has beaten a challenge from a group of pharmaceutical rivals to its patent for a hepatitis C drug, dealing a fresh blow to medical nonprofits that have fought to open the door to cheaper generics.
-
June 10, 2024
Oil Well Plugging System Does Not Infringe Rival's Patent
Two technology companies have won a declaration that their oil well plugging device does not infringe a rival's patents over similar tech, convincing an intellectual property officer that the systems "wash" disused wells in different ways.
-
June 10, 2024
Luxembourg Research Institute Loses Database Patent Bid
A Luxembourg research organization on Monday lost its bid to register a patent for algorithms for updating databases, with a European Patent Office appeals board concluding that the method was obvious to a person skilled in computing.
-
June 10, 2024
Amazon Sold Facial Tech To Russia, Ex-Employee Alleges
A former Amazon worker has alleged that the technology giant sold facial recognition software to a Russian company in violation of U.K. sanctions.
-
June 07, 2024
Crypto Developers Fight To Gag Wright After 'Satoshi' Trial
A group of cryptocurrency asset developers urged a London judge on Friday to order Australian computer scientist Craig Wright to never again assert that he is the pseudonymous inventor of bitcoin Satoshi Nakamoto, arguing it was the best way to end his "campaign of dishonesty."
-
June 07, 2024
5 Questions For Finnegan UK TM Chief Clare Cornell
Clare Cornell, the head of Finnegan Henderson Farabow Garrett & Dunner LLP's trademark group in London, talks to Law360 about the appeal of working on trademarks and how Finnegan's practice has evolved since she joined in 2016.
-
June 07, 2024
Patent Firm Seeks To Ax Claim Over £1.5M Settlement Advice
Patent solicitors Atkinson Wheller Ltd. asked a court Friday to throw out a negligence claim brought on behalf of a former client, because the deed transferring the claim to a law firm was "void and unenforceable."
-
June 07, 2024
UK Litigation Roundup: Here's What You Missed In London
The past week in London has seen British broadcaster GB News hit with a libel claim by climate activist Dale Vince, MGM take aim at an immersive events company over intellectual property rights to the James Bond franchise, and law firms Stephenson Harwood and Bowen-Morris & Partners tackle a contracts claim by investment adviser Yieldstreet. Here, Law360 looks at these and other new claims in the U.K.
-
June 07, 2024
Nestlé Loses EU Patent For Sterile Baby Food
The appeals division of the European Union's patent authority has pulled the plug on a patent owned by Nestlé for a type of sterilized baby food after a German law firm persuaded an appeals board that it was too vague.
-
June 07, 2024
BASF Loses Bid To Block Rival's Plastics Patent
Austrian plastics maker Borealis has fought off BASF's second attack on a patent related to a commodity plastic used in products like surgical masks, after European officials ruled that the combined use of specific components was inventive.
-
June 06, 2024
UK, US Team Up On Standard-Essential Patents
The U.S. Patent and Trademark Office and U.K. Intellectual Property Office each announced a five-year agreement Thursday to collaborate on policy for standard-essential patents.
-
June 06, 2024
'Brussels Effect' Of EU's AI Act Is Uncertain, Legal Pros Say
BigLaw attorneys advising international clients on the European Union's AI Act tell Law360 there are significant uncertainties over vague terms in the 458-page statute, how its steep eight-figure fines will be enforced, and whether it will set a new standard globally as part of the "Brussels effect."
-
June 06, 2024
Romania Becomes 18th EU State To Join Unified Patent Court
European officials said Wednesday that Romania has joined Europe's unitary patent system after ratifying the agreement just ahead of its first anniversary.
-
June 06, 2024
Abbott Asks UPC To Nix Dexcom Glucose Monitor Patent
Abbott Laboratories has asked Europe's patent court to revoke a Dexcom patent over a glucose monitoring system, the latest rift between the rivals as they vie for dominance of a multibillion-dollar market.
-
June 06, 2024
Patent Trial Over AstraZeneca Unit Soliris Drug Set For 2025
A London judge Thursday agreed to list a quarrel among three pharmaceutical companies over Alexion's patent for a drug that treats rare blood diseases for trial in early 2025, finding there is "some degree of urgency" to resolve the dispute.
-
June 06, 2024
Regeneron Sees Infringement In Rivals' Biosimilar Eye Meds
Regeneron has defended the validity of its U.K. eye medicine patents in a London court amid a feud with a biosimilars specialist and its licensing partner, alleging that their plans to market an alternate version will infringe its exclusive right to produce the drug.
-
June 06, 2024
Artist Claims Royalties For Queen's Holographic Portrait
The artist behind a holographic portrait of the queen has fought allegations of copyright infringement, accusing the arts charity that commissioned him of exhibiting some other works for over a decade without paying him.
-
June 05, 2024
K&L Gates Adds Ex-Norton Rose IP Team In Frankfurt
K&L Gates LLP has bolstered its intellectual property practice in its 30-attorney Frankfurt office with the addition of a team from Norton Rose Fullbright LLP, including a partner who works closely with fashion and luxury product clients.
-
June 05, 2024
Nestle Can't Get 'Vitaliv' TM Due To Existing Vita-Cola Brand
Nestle has lost its bid to get a trademark for a range of "Vitaliv" branded beverages, after European officials ruled that it wasn't distinct enough from a German rival's "Vita-Cola" sign to stop buyers from confusing the two.
-
June 05, 2024
Swiss Bank Escapes Investor's Unlawful Conspiracy Claim
Lombard Odier has partially succeeded in blocking the claims of an investor who says the private bank withheld inside information about the merits of a British nanotech company's U.S. legal dispute with Samsung to convince him to buy shares in the company just before its price tanked.
-
June 05, 2024
Amgen Defeats Challenge To European Heart Drug Patent
Amgen and fellow biotech company Cytokinetics fought off a second attack on a potential new treatment for heart failure, as European patent officials ruled that the benefits of a specific salt they used were unexpected and inventive.
-
June 05, 2024
McDonald's Loses 'Big Mac' TM Rights Over Poultry In EU
A European Union court on Wednesday stripped McDonald's of its right to use the "Big Mac" trademark on chicken sandwiches in the bloc, ruling that the fast food giant had failed to put the sign to proper use on poultry products in recent years.
-
June 05, 2024
Enterprise Can't Drive 'Commute' TM Into EU Market
Vehicle rental company Enterprise cannot register its "Commute With Enterprise" trademark in the European Union because consumers could confuse the sign with a transportation tech company's "Qommute" sign, a court in the bloc ruled Wednesday.
-
June 05, 2024
Hair Care Brand's 'Wow' TM Challenge Backfires At UKIPO
Premium hair care brand Color Wow has failed to convince U.K. intellectual property officials to block a budget clothes retailer's "Wow London" trademark, losing out on its own "Wow" trademark in the process.
-
June 04, 2024
Illumina Board Puts Grail Spinoff In Motion After EU OK
Illumina Inc. said Tuesday that its board had approved a spinoff of its cancer detection company following a push by activist heavyweight Carl Icahn and an ultimate order from European authorities to dispose of the asset.
Expert Analysis
-
A Successful Follow-On Inter Partes Review Petition
The Patent Trial and Appeal Board's recent decision in World Bottling Cap shows that a second petition for inter partes review will be considered by the PTAB when the facts and additional prior art warrant, says Ted Baroody of Carstens & Cahoon LLP.
-
Get Ready For EU Unified Patent Court And Unitary Patent
Big change is coming to European patent litigation — as early as January 2017, a new single Unified Patent Court will commence operation. The time for U.S. companies with European patents to start planning and preparing is now, say Ron Lopez and Jennifer Hayes of Nixon Peabody LLP.
-
Effective IP Enforcement Is Taking Shape In China
As the Chinese economy grows and becomes more intertwined with other world economies, non-Chinese intellectual property rights holders in the energy sector must understand new enforcement mechanisms under the National Intellectual Property Rights Strategy Action Plan to maintain a competitive IP strategy, say Brad Chin and Kevin Tamm of Bracewell & Giuliani LLP.
-
Privacy, Security, Risk: What You Missed At IAPP Conference
A few weeks ago, privacy and security professionals from around the globe gathered for the second joint conference between the International Association of Privacy Professionals and the Cloud Security Alliance Congress. Aravind Swaminathan, Antony Kim and Emily Tabatabai of Orrick Herrington & Sutcliffe LLP offer seven key takeaways.
-
Approach To '2nd Medical Use' Claims Varies Across EU
A number of recent court decisions have highlighted important gaps and a lack of consensus between key EU member states on the law regarding infringement of second medical use patents. The rulings also demonstrate how differences in the drug dispensing and reimbursement systems between different EU countries can influence the nature of the relief available, say attorneys with Jones Day.
-
5 Ways University Students, Faculty Risk Forfeiting IP Rights
Although academic institutions recognize the value of translating research into patents, licenses and commercial products, there remains a strong scholastic motivation for faculty and students to publish their research findings in journals and at academic conferences to advance their reputation and career. As a result, intellectual property is often an afterthought, say attorneys with Meunier Carlin & Curfman LLC.
-
EPO Set To Clarify Priority And Divisional Application Problem
In a recent decision, one European Patent Office Board of Appeal finally decided that the question of the possibility of poisonous priority and divisional applications should be settled once and for all. The Enlarged Board of Appeal may simply do away with poisonous applications or possibly formulate detailed criteria for the assessment of partial priority, say attorneys with CH KILGER Anwaltspartnerschaft mbB.
-
EU High Court Sets Important SEP Precedent
The EU high court's recent ruling in Huawei Technologies Co. Ltd. v. ZTE Corp. provided a significant amount of guidance on standard-essential patents, injunctions and abuse of dominance but addresses only some of the legal questions that SEP holders and alleged infringers face in these situations, and even the questions addressed are in part expressed in very broad terms inviting different interpretations, say Axel Gutermuth and Christopher Stothers of Arnold & Porter LLP.
-
Procuring Personalized Medicine Patents In US Vs. Europe
In the United States, many patent claims related to personalized medicine are being challenged based on patentable subject matter, whereas in Europe, most claims are questioned based on novelty and inventive step, says Gabriela Coman of Dickstein Shapiro LLP.
-
Rival Global Views On Patent Disclosures
When it comes to patent disclosure requirements, terminology varies widely across the world. But the major national patent players seem to break down into two chief opposing views on just how much support patent claims and amendments require in originally filed applications, says Stephen Keefe of Rabin & Berdo PC.
-
Use Strategic Continuation Practice To Monetize IP
Continuation patent applications provide a useful mechanism to raise the overall quality of patents within a given portfolio, says Michael Moore, intellectual property and deputy general counsel at Rambus Inc.
-
Using Patents To Curtail Climate Change: A Proposal
Last fall, 74 countries and more than 1,000 businesses signed a declaration calling on all nations to price carbon dioxide and other greenhouse gases, yet the prospects of meaningful government action are dim. We see a possible solution in our patent system — impose a flexible license fee tied to greenhouse gas emissions, say attorneys with Klarquist Sparkman LLP, Green Patent Law, Robins Kaplan LLP, Burns & Levinson LLP and Susman Godfrey LLP.
-
22 Ways Congress Can Save Section 101
As delightful as the post-Alice patent-invalidating trend may be to patent defendants, it has created enormous consequences for companies that rely on patent protection to protect crucial technology assets, including the loss of business contracts, disrupted partnerships and increased difficulty in obtaining venture funding. It is time for Congress to act, says Robert Sachs of Fenwick & West LLP.
-
Top 5 IPR Discovery Tips For Patent Owners
Recent Patent Trial and Appeal Board orders shed some light on how parties can use the inter partes review discovery periods to their best advantage, says Carly Levin of Venable LLP.
-
What To Know About Extending Patent Term In Southeast Asia
For pharmaceutical products, the most general form of extended patent protection available in Southeast Asia is currently data exclusivity, says James Kinnaird of Marks & Clerk.